Spark Therapeutics Has a Viable Hep A Program on Its Hands Spark Therapeutics Inc (NASDAQ:ONCE) shares are jumping almost 20% after the biotech …
Celator Pharmaceuticals Inc Roth Capital analyst Joseph Pantginis weighs in today on Celator Pharmaceuticals Inc (NASDAQ:CPXX), after the biotech company announced that the FDA granted Breakthrough Therapy …
